B-cell neoplasms and human carcinomas such as melanoma, ovarian cancer, glioblastoma, and breast cancer have been found to implicate TRAF1, TRAF2, TRAF3, and TRAF5 [15–20]. This evidence concerns the gene TRAF5 and melanoma.